Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Mikol

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Diabetes, Obesity & Metabolism|March 21, 2020
Incretin combination therapy for the treatment of non-alcoholic steatohepatitisAimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, et al.
Journal of Clinical and Translational Hepatology|January 15, 2021
A 3D Human Liver Model of Nonalcoholic SteatohepatitisMarion Duriez, Agnes Jacquet, Lucile Hoet, et al.
Stem Cell Reports|August 6, 2019
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte PathologyMatthew J Birket, Sophie Raibaud, Miriam Lettieri, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Allergy|July 11, 2018
Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis modelAngela Rouyar, Marion Classe, Raphael Gorski, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
JCI Insight|June 8, 2018
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patientsMarsilio Adriani, Petra Nytrova, Cyprien Mbogning, et al.
Journal of Medicinal Chemistry|October 7, 2011
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperoneFrançois Vallée, Chantal Carrez, Fabienne Pilorge, et al.
Scientific Reports|January 7, 2015
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodentsGuy Griebel, Philippe Pichat, Sandra Beeské, et al.
Plos One|June 25, 2020
ABHD11, a new diacylglycerol lipase involved in weight gain regulationJohanna Escoubet, Mireille Kenigsberg, Murielle Derock, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|March 21, 2020
Incretin combination therapy for the treatment of non-alcoholic steatohepatitisAimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, et al.
Journal of Clinical and Translational Hepatology|January 15, 2021
A 3D Human Liver Model of Nonalcoholic SteatohepatitisMarion Duriez, Agnes Jacquet, Lucile Hoet, et al.
Stem Cell Reports|August 6, 2019
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte PathologyMatthew J Birket, Sophie Raibaud, Miriam Lettieri, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Allergy|July 11, 2018
Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis modelAngela Rouyar, Marion Classe, Raphael Gorski, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
JCI Insight|June 8, 2018
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patientsMarsilio Adriani, Petra Nytrova, Cyprien Mbogning, et al.
Journal of Medicinal Chemistry|October 7, 2011
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperoneFrançois Vallée, Chantal Carrez, Fabienne Pilorge, et al.
Scientific Reports|January 7, 2015
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodentsGuy Griebel, Philippe Pichat, Sandra Beeské, et al.
Plos One|June 25, 2020
ABHD11, a new diacylglycerol lipase involved in weight gain regulationJohanna Escoubet, Mireille Kenigsberg, Murielle Derock, et al.
Pageof 3